FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Stuart Johnson

Research Profile

Living Beings

Disorders

Chemicals & Drugs

Procedures

Physiology

Bacterial Drug Resistance

Phenomena

Geographic Areas

United States

Concepts & Ideas

Virulence

Co-author Network

Publications

TOP 3
Susan M Pacheco; Stuart Johnson
Important clinical advances in the understanding of Clostridium difficile infection.
S Tyler Phillips; Susan P Sambol; Stuart Johnson; Kristin Nagaro; Dale N Gerding
Susceptibility of hamsters to infection by historic and epidemic BI Clostridium difficile strains during daily administration of three fluoroquinolones.
Stuart Johnson; Christopher Schriever; Ursula Patel; Toral Patel; David W Hecht; Dale N Gerding
Rifaximin Redux: treatment of recurrent Clostridium difficile infections with rifaximin immediately post-vancomycin treatment.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Stuart Johnson (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Susan M Pacheco; Stuart Johnson
Important clinical advances in the understanding of Clostridium difficile infection.
Current opinion in gastroenterology 2013;29(1):42-8.
2011: S Tyler Phillips; Susan P Sambol; Stuart Johnson; Kristin Nagaro; Dale N Gerding
Susceptibility of hamsters to infection by historic and epidemic BI Clostridium difficile strains during daily administration of three fluoroquinolones.
Anaerobe 2011;17(4):166-9.
2009: Stuart Johnson; Christopher Schriever; Ursula Patel; Toral Patel; David W Hecht; Dale N Gerding
Rifaximin Redux: treatment of recurrent Clostridium difficile infections with rifaximin immediately post-vancomycin treatment.
Anaerobe 2009;15(6):290-1.
2009: Jaime Belmares; Stuart Johnson; Jorge P Parada; Mary M Olson; Connie Clabots; Kristine M Bettin; Lance R Peterson; Dale N Gerding
Molecular epidemiology of Clostridium difficile over the course of 10 years in a tertiary care hospital.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;49(8):1141-7.
2009: Stuart Johnson
Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes.
The Journal of infection 2009;58(6):403-10.
2009: June M McKoy; Charles L Bennett; Marc H Scheetz; Virginia Differding; Kevin L Chandler; Kimberly K Scarsi; Paul R Yarnold; Sarah Sutton; Frank J Palella; Stuart Johnson; Eniola Obadina; Dennis W Raisch; Jorge P Parada
Hepatotoxicity associated with long- versus short-course HIV-prophylactic nevirapine use: a systematic review and meta-analysis from the Research on Adverse Drug events And Reports (RADAR) project.
Drug safety : an international journal of medical toxicology and drug experience 2009;32(2):147-58.
2008: Jaime Belmares; Dale N Gerding; Glenn Tillotson; Stuart Johnson
Measuring the severity of Clostridium difficile infection: implications for management and drug development.
Expert review of anti-infective therapy 2008;6(6):897-908.
2008: Michael A Jhung; Angela D Thompson; George Killgore; Walter E Zukowski; Glenn Songer; Michael Warny; Stuart Johnson; Dale N Gerding; L Clifford McDonald; Brandi Limbago
Toxinotype V Clostridium difficile in humans and food animals.
Emerging infectious diseases 2008;14(7):1039-45.
2008: George Killgore; Angela Thompson; Stuart Johnson; Jon Brazier; Ed Kuijper; Jacques Pepin; Eric Frost; Paul Savelkoul; Brad Nicholson; Renate J van den Berg; Haru Kato; Susan P Sambol; Walter Zukowski; Christopher Woods; Brandi Limbago; Dale N Gerding; L Clifford McDonald
Comparison of seven techniques for typing international epidemic strains of Clostridium difficile: restriction endonuclease analysis, pulsed-field gel electrophoresis, PCR-ribotyping, multilocus sequence typing, multilocus variable-number tandem-repeat analysis, amplified fragment length polymorphism, and surface layer protein A gene sequence typing.
Journal of clinical microbiology 2008;46(2):431-7.
2007: Nadia Razaq; Susan P Sambol; Kristin Nagaro; Walter Zukowski; Adam Cheknis; Stuart Johnson; Dale N Gerding
Infection of hamsters with historical and epidemic BI types of Clostridium difficile.
The Journal of infectious diseases 2007;196(12):1813-9.
2007: David W Hecht; Minerva A Galang; Susan P Sambol; James R Osmolski; Stuart Johnson; Dale N Gerding
In vitro activities of 15 antimicrobial agents against 110 toxigenic clostridium difficile clinical isolates collected from 1983 to 2004.
Antimicrobial agents and chemotherapy 2007;51(8):2716-9.
2007: Stuart Johnson; Christopher Schriever; Minerva Galang; Ciarán P Kelly; Dale N Gerding
Interruption of recurrent Clostridium difficile-associated diarrhea episodes by serial therapy with vancomycin and rifaximin.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;44(6):846-8.
2006: Barbara Geric; Robert J Carman; Marjan Rupnik; Christopher W Genheimer; Susan P Sambol; David M Lyerly; Dale N Gerding; Stuart Johnson
Binary toxin-producing, large clostridial toxin-negative Clostridium difficile strains are enterotoxic but do not cause disease in hamsters.
The Journal of infectious diseases 2006;193(8):1143-50.
2006: Matthew H Samore; Lata Venkataraman; Paola C DeGirolami; Michelle M Merrigan; Stuart Johnson; Dale N Gerding; Yehuda Carmeli; Stephan Harbarth
Genotypic and phenotypic analysis of Clostridium difficile correlated with previous antibiotic exposure.
Microbial drug resistance (Larchmont, N.Y.) 2006;12(1):23-8.
2005: L Clifford McDonald; George Killgore; Angela Thompson; Robert C Owens; Sophia V Kazakova; Susan P Sambol; Stuart Johnson; Dale N Gerding
An epidemic, toxin gene-variant strain of Clostridium difficile.
The New England journal of medicine 2005;353(23):2433-41.
2005: Marjan Rupnik; Bruno Dupuy; Neil F Fairweather; Dale N Gerding; Stuart Johnson; Ingo Just; David M Lyerly; Michel R Popoff; Julian I Rood; Abraham L Sonenshein; Monica Thelestam; Brendan W Wren; Tracy D Wilkins; Christoph von Eichel-Streiber
Revised nomenclature of Clostridium difficile toxins and associated genes.
Journal of medical microbiology 2005;54(Pt 2):113-7.
2004: Barbara Geric; Marjan Rupnik; Dale N Gerding; Miklavz Grabnar; Stuart Johnson
Distribution of Clostridium difficile variant toxinotypes and strains with binary toxin genes among clinical isolates in an American hospital.
Journal of medical microbiology 2004;53(Pt 9):887-94.
2003: Michelle M Merrigan; Susan P Sambol; Stuart Johnson; Dale N Gerding
Prevention of fatal Clostridium difficile-associated disease during continuous administration of clindamycin in hamsters.
The Journal of infectious diseases 2003;188(12):1922-7.
2003: Barbara Geric; Stuart Johnson; Dale N Gerding; Miklavz Grabnar; Marjan Rupnik
Frequency of binary toxin genes among Clostridium difficile strains that do not produce large clostridial toxins.
Journal of clinical microbiology 2003;41(11):5227-32.
2003: Michelle M Merrigan; Susan P Sambol; Stuart Johnson; Dale N Gerding
Susceptibility of hamsters to human pathogenic Clostridium difficile strain B1 following clindamycin, ampicillin or ceftriaxone administration.
Anaerobe 2003;9(2):91-5.
2003: Stuart Johnson; Susan P Sambol; Jon S Brazier; Michel Delmée; Véronique Avesani; Michelle M Merrigan; Dale N Gerding
International typing study of toxin A-negative, toxin B-positive Clostridium difficile variants.
Journal of clinical microbiology 2003;41(4):1543-7.
2002: Susan P Sambol; Michelle M Merrigan; Janet K Tang; Stuart Johnson; Dale N Gerding
Colonization for the prevention of Clostridium difficile disease in hamsters.
The Journal of infectious diseases 2002;186(12):1781-9.
2002: Endale T Mekonen; Dale N Gerding; Susan P Sambol; Jean M Pottinger; Joseph J Pulvirenti; Dayle Marsh; Frank Kocka; Stuart Johnson
Predominance of a single restriction endonuclease analysis group with intrahospital subgroup diversity among Clostridium difficile isolates at two Chicago hospitals.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2002;23(11):648-52.
2001: Stuart Johnson; S A Kent; K J O'Leary; Michelle M Merrigan; Susan P Sambol; Lance R Peterson; Dale N Gerding
Fatal pseudomembranous colitis associated with a variant clostridium difficile strain not detected by toxin A immunoassay.
Annals of internal medicine 2001;135(6):434-8.
2001: Susan P Sambol; J K Tang; Michelle M Merrigan; Stuart Johnson; Dale N Gerding
Infection of hamsters with epidemiologically important strains of Clostridium difficile.
The Journal of infectious diseases 2001;183(12):1760-6.
2000: Susan P Sambol; Michelle M Merrigan; David M Lyerly; Dale N Gerding; Stuart Johnson
Toxin gene analysis of a variant strain of Clostridium difficile that causes human clinical disease.
Infection and immunity 2000;68(10):5480-7.
2000: Berta Rodes; Hsi Liu; Stuart Johnson; R George; Bret Steiner
Molecular cloning of a gene (poIA) coding for an unusual DNA polymerase I from Treponema pallidum.
Journal of medical microbiology 2000;49(7):657-67.